Role of boost radiotherapy for local control of pure ductal carcinoma in situ after breast-conserving surgery: a multicenter, retrospective study of 622 patients.

CONCLUSIONS: Radiotherapy boost did not improve the risk of IBTR. Boost radiotherapy was more common in patients with high-risk disease. Tumor size and re-excision were significant independent prognostic factors. PMID: 31264148 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31264148?dopt=Abstract

Source: Clinical Breast Cancer - June 30, 2019 Category: Cancer & Oncology Authors: Cambra MJ, Moreno F, Sanz X, Anglada L, Mollà M, Reyes V, Arenas M, Pedro A, Ballester R, García V, Casals J, Cusidó M, Jimenez C, Escribà JM, Macià M, Solé JM, Arcusa A, Seguí MA, Gonzalez S, Farrús B, Biete A Tags: Clin Transl Oncol Source Type: research